Čájehuvvojit 1 - 4 oktiibuot 4 bohtosis ohcui CDC Prevention Epicenter Program', ohcanáigi: 0,02s Aiddostahte ozu
  1. 1
    Utilizing the focused conversation method in qualitative public health research: a team-based approach

    Utilizing the focused conversation method in qualitative public health research: a team-based approach Dahkki Charissa Fritzen-Pedicini, Susan C. Bleasdale, Lisa M. Brosseau, Donna Moritz, Monica Sikka, Emily Stiehl, Rachael M. Jones, for the CDC Prevention Epicenter Program

    Almmustuhtton 2019-05-01
    Viečča ollesdeavstta
    Artihkal
  2. 2
    Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides difficile infection from the open-label PUNCH CD study

    Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides difficile infection from the open-label PUNCH CD study Dahkki Amy Langdon, Drew J. Schwartz, Christopher Bulow, Xiaoqing Sun, Tiffany Hink, Kimberly A. Reske, Courtney Jones, Carey-Ann D. Burnham, Erik R. Dubberke, Gautam Dantas, for the CDC Prevention Epicenter Program

    Almmustuhtton 2021-02-01
    Viečča ollesdeavstta
    Artihkal
  3. 3
    Effect of meteorological factors and geographic location on methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci colonization in the US.

    Effect of meteorological factors and geographic location on methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci colonization in the US. Dahkki Natalia Blanco, Eli Perencevich, Shan Shan Li, Daniel J Morgan, Lisa Pineles, J Kristie Johnson, Gwen Robinson, Deverick J Anderson, Jesse T Jacob, Lisa L Maragakis, Anthony D Harris, CDC Prevention Epicenter Program

    Almmustuhtton 2017-01-01
    Viečča ollesdeavstta
    Artihkal
  4. 4
    Impact of investigational microbiota therapeutic RBX2660 on the gut microbiome and resistome revealed by a placebo-controlled clinical trial

    Impact of investigational microbiota therapeutic RBX2660 on the gut microbiome and resistome revealed by a placebo-controlled clinical trial Dahkki Suryang Kwak, JooHee Choi, Tiffany Hink, Kimberly A. Reske, Kenneth Blount, Courtney Jones, Margaret H. Bost, Xiaoqing Sun, Carey-Ann D. Burnham, Erik R. Dubberke, Gautam Dantas, for the CDC Prevention Epicenter Program

    Almmustuhtton 2020-08-01
    Viečča ollesdeavstta
    Artihkal

Ohcanreaiddut: